Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study

Rosana Carvalho Silva,Paolo Martini,Christa Hohoff,Stefania Mattevi,Marco Bortolomasi,Maria Abate,Valentina Menesello,Massimo Gennarelli,Bernhard T. Baune,Alessandra Minelli
DOI: https://doi.org/10.1186/s13148-024-01704-z
2024-07-20
Clinical Epigenetics
Abstract:Electroconvulsive therapy (ECT) benefits patients with treatment-resistant depression (TRD), but the underlying biological processes are unclear. We conducted an epigenome-wide association study in 32 TRD patients undergoing ECT to depict ECT-associated methylation changes. Illness severity and ECT outcomes were assessed with the Montgomery–Åsberg Depression Rating Scale at baseline (T0) and 1 month after its end (T1). Methylation was profiled at T0 and T1 with the Illumina Infinium Methylation EPIC BeadChip array.
oncology,genetics & heredity
What problem does this paper attempt to address?